glp-1 for diabetes and weight loss GLP-1 Medications Infographic | Medidex

#drugdiscovery #drugdevelopment #drugdiscoveryanddevelopment To view or add a comment, sign in FDA accepts license application for a treatment of generalised pustular psoriasis The US Food and Drug Administration (FDA) has accepted the filing of a Biologics License Application (BLA) for imsidolimab for the treatment of generalised pustular psoriasis (GPP), with a target action date of 12 December 2026

Products sold as TB-500 or BPC-157 may be underdosed, contaminated, or entirely fake

Estudos pr-clnicos demonstram propriedades de reparao tecidual (tendes, ligamentos, msculos), proteo gastrointestinal (lceras, colite) e neuroproteo

This is where GLP-1 medications introduce an added layer of complexity

Several important limitations should be kept in mind when interpreting these findings